ALX ONCOLOGY HOLDINGS INC. - COMMON STOCK

1.3300

14-November-24 16:45:00

15 minutes delayed

Stocks

-0.0100

-0.75%

Today's range

1.3250 - 1.3800

ISIN

N/A

Source

NASDAQ

ALX Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones

18 Mar 2021 16:05:00 By Nasdaq GlobeNewswire
ALX Oncology Announces Appointment of Sophia Randolph, M.D., Ph.D., to Board of Directors

15 Mar 2021 07:00:02 By Nasdaq GlobeNewswire
ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics

04 Mar 2021 16:05:00 By Nasdaq GlobeNewswire
ALX Oncology to Participate at H.C. Wainwright Global Life Sciences Conference

02 Mar 2021 07:00:02 By Nasdaq GlobeNewswire
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2021

11 Jan 2021 07:00:01 By Nasdaq GlobeNewswire
ALX Oncology to Present at 39th Annual J.P. Morgan Healthcare Conference

05 Jan 2021 07:00:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.